Results 1 to 10 of about 45,801 (303)
Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro [PDF]
Alzheimer’s disease (AD) and Parkinson’s disease (PD), including dementia with Lewy bodies (DLB), account for the majority of dementia cases worldwide.
Janett Köppen +14 more
doaj +2 more sources
Adsorption of Amyloid Beta Peptide by Metal–Organic Frameworks [PDF]
Metal-organic frameworks (MOFs) are capable of adsorbing a wide range of molecules. In addition to the more commonly investigated small molecules, researchers have demonstrated that MOFs adsorb much larger molecules, such as proteins and peptides. We have investigated whether MOFs are capable of adsorbing amyloid beta peptide.
Zachary L. Mensinger +2 more
openalex +4 more sources
NMR studies of the amyloid beta-peptide
The Amyloid beta peptide (Ab) is related to Alzheimer’s disease and is suggested to be the molecular pathogenic species of the disease, probably through the neurotoxic effect of Ab oligomers. Here the results from biophysical studies of Ab and fragments thereof, are presented.
Jens Danielsson
openalex +2 more sources
DHA supplemented in peptamen diet offers no advantage in pathways to amyloidosis: is it time to evaluate composite lipid diet? [PDF]
Numerous reports have documented the beneficial effects of dietary docosahexaenoic acid (DHA) on beta-amyloid production and Alzheimer's disease (AD).
Zareen Amtul +5 more
doaj +1 more source
Characterizing Heparin Tetrasaccharides Binding to Amyloid-Beta Peptide [PDF]
The aggregation of β-amyloid peptide (Aβ) is one potential cause for Alzheimer’s disease (AD). Heparin can either promote or inhibit Aβ aggregation. The sulfation pattern and chain size determine its binding affinity and its role. Using 2D-NMR analysis and molecular modelling, the binding motif of heparin oligoaccharides to Aβ was determined to be HexA-
Xiang Zhou +5 more
openaire +3 more sources
Alzheimer´s disease is characterized by hyperphosphorylated tau neurofibrillary tangles and beta-amyloid plaques. Both molecules can be easily measured in human fluids or tissue extracts by immunoassays.
Dhwani S. Korde, Christian Humpel
doaj +1 more source
Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease. [PDF]
Neprilysin is a transmembrane zinc metallopeptidase that degrades a wide range of peptide substrates. It has received attention as a potential therapy for Alzheimer's disease due to its ability to degrade the peptide amyloid beta.
Carl I Webster +11 more
doaj +1 more source
Amyloid-β acts as a regulator of neurotransmitter release disrupting the interaction between synaptophysin and VAMP2. [PDF]
BACKGROUND: It is becoming increasingly evident that deficits in the cortex and hippocampus at early stages of dementia in Alzheimer's disease (AD) are associated with synaptic damage caused by oligomers of the toxic amyloid-β peptide (Aβ42).
Alifragis, P +5 more
core +5 more sources
The amyloid cascade hypothesis proposes that excessive accumulation of amyloid beta-peptides is the initiating event in Alzheimer's disease. These neurotoxic peptides are generated from the amyloid precursor protein via sequential cleavage by β- and γ ...
Edward T Parkin +3 more
doaj +1 more source
Beta-amyloid (Aβ) peptides have been considered as the core biomarkers for early diagnosis of Alzheimer's disease. Electrochemiluminescent (ECL) and photoelectrochemical (PEC) biosensors are two promising methods for disease diagnosis in view of their ...
Yunxiao Feng, Ming La
doaj +1 more source

